A Study of Evacetrapib (LY2484595) in Combination With Atorvastatin in Japanese Participants With Primary Hypercholesterolemia

• Status: Terminated
• Trial end date: 2015-11-01

Summary

The main purpose of this study is to evaluate the efficacy and safety of the study drug known as evacetrapib when administered in combination with atorvastatin for 12 weeks in Japanese participants with primary hypercholesterolemia.

• Phase: Phase 3

Details

• Lead Sponsor: Eli Lilly and Company
• Treatments: Atorvastatin; Atorvastatin Calcium; Evacetrapib; Ezetimibe